What is Viking Therapeutics's tax on share settlement?

Viking Therapeutics (VKTX) reported tax on share settlement of $0 in Q4 2025.

What does tax on share settlement mean?

Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.

Rhythm Pharmaceuticals, Inc.RYTM

$8.46M—

BioCryst PharmaceuticalsBCRX

$1.19M-12.1%

Revenue-—

Operating income-$164.1M-196%

Net income-$158.3M-247%

EPS (diluted)-$1.37-234%

Cash & equivalents$118.1M+211%

Total debt$137.0K-87.8%

Total equity$501.9M-40.7%

Total assets$608.2M-29.8%

Operating cash flow-$114.0M-118%

Market cap$4.04B+38.7%

Return on equity-70%-94.5pp

Debt / equity0×0.0×

Current ratio5.7×-38.5×

Reported directly by Viking Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation.

The official record: Viking Therapeutics’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Viking Therapeutics's tax on share settlement?: Viking Therapeutics (VKTX) reported tax on share settlement of $0 in Q4 2025.
What does tax on share settlement mean?: Cash paid to tax authorities for employee share vesting, where the company withholds shares and pays the tax obligation in cash.